Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 24 of 48 for:    "Acute Lymphoblastic Leukemia, Childhood" | "Pegaspargase"

Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03571321
Recruitment Status : Not yet recruiting
First Posted : June 27, 2018
Last Update Posted : October 15, 2018
Sponsor:
Collaborator:
Incyte Corporation
Information provided by (Responsible Party):
University of Chicago

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : September 5, 2022
Estimated Study Completion Date : September 5, 2024